Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
1.560
-0.080 (-4.88%)
At close: Feb 21, 2025, 4:00 PM
1.610
+0.050 (3.21%)
After-hours: Feb 21, 2025, 6:27 PM EST
Outlook Therapeutics Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
| Cost of Revenue | 46.89 | 41.76 | 26.45 | 42.33 | 38.96 | 26.34 | |
| Gross Profit | -46.89 | -41.76 | -26.45 | -42.33 | -38.96 | -26.34 | |
| Selling, General & Admin | 36.09 | 29.94 | 26.67 | 20.74 | 12.77 | 9.97 | |
| Operating Expenses | 36.09 | 29.94 | 26.67 | 20.74 | 12.77 | 9.97 | |
| Operating Income | -82.99 | -71.7 | -53.13 | -63.07 | -51.73 | -36.31 | |
| Interest Expense | -3.16 | -3.16 | -2.53 | -1.49 | -0.94 | -1.76 | |
| Interest & Investment Income | 0.77 | 0.91 | 0.97 | - | - | - | |
| Earnings From Equity Investments | -0.14 | -0.1 | -0.01 | -0.05 | -0.05 | - | |
| Other Non Operating Income (Expenses) | 41.47 | 1.15 | 0.05 | 0.47 | -0.45 | 1.98 | |
| EBT Excluding Unusual Items | -44.04 | -72.91 | -54.65 | -64.14 | -53.16 | -36.09 | |
| Asset Writedown | - | - | - | - | - | -0.53 | |
| Other Unusual Items | -2.77 | -2.46 | -4.33 | -1.91 | - | -1.9 | |
| Pretax Income | -46.81 | -75.36 | -58.98 | -66.05 | -53.16 | -38.51 | |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | -3.27 | |
| Earnings From Continuing Operations | -46.81 | -75.37 | -58.98 | -66.05 | -53.16 | -35.24 | |
| Net Income | -46.81 | -75.37 | -58.98 | -66.05 | -53.16 | -35.24 | |
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 13.63 | |
| Net Income to Common | -46.81 | -75.37 | -58.98 | -66.05 | -53.16 | -48.87 | |
| Shares Outstanding (Basic) | 21 | 19 | 13 | 11 | 8 | 4 | |
| Shares Outstanding (Diluted) | 21 | 19 | 13 | 11 | 8 | 4 | |
| Shares Change (YoY) | 65.29% | 48.29% | 17.96% | 38.91% | 110.43% | 298.84% | |
| EPS (Basic) | -2.19 | -4.06 | -4.72 | -6.23 | -6.96 | -13.47 | |
| EPS (Diluted) | -2.19 | -4.06 | -4.72 | -6.23 | -6.96 | -13.47 | |
| Free Cash Flow | -66.73 | -68.79 | -42.97 | -56.67 | -54.25 | -31.79 | |
| Free Cash Flow Per Share | -3.12 | -3.71 | -3.44 | -5.34 | -7.11 | -8.76 | |
| EBITDA | -82.87 | -71.59 | -53.08 | -62.87 | -51.46 | -35.76 | |
| D&A For EBITDA | 0.11 | 0.11 | 0.04 | 0.2 | 0.26 | 0.55 | |
| EBIT | -82.99 | -71.7 | -53.13 | -63.07 | -51.73 | -36.31 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.